ProShare Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301K | Sell |
9,493
-2,480
| -21% | -$67.6K | ﹤0.01% | 1339 |
|
|
2025
Q4 | $325K | Buy |
11,973
+773
| +7% | +$20.4K | ﹤0.01% | 1405 |
|
|
2025
Q3 | $290K | Sell |
11,200
-2,230
| -17% | -$51.7K | ﹤0.01% | 1450 |
|
|
2025
Q2 | $273K | Sell |
13,430
-556
| -4% | -$10.8K | ﹤0.01% | 1513 |
|
|
2025
Q1 | $254K | Sell |
13,986
-4,206
| -23% | -$94K | ﹤0.01% | 1523 |
|
|
2024
Q4 | $460K | Buy |
18,192
+5,986
| +49% | +$163K | ﹤0.01% | 1321 |
|
|
2024
Q3 | $415K | Buy |
12,206
+3,882
| +47% | +$148K | ﹤0.01% | 1256 |
|
|
2024
Q2 | $308K | Sell |
8,324
-2,842
| -25% | -$107K | ﹤0.01% | 1276 |
|
|
2024
Q1 | $469K | Buy |
11,166
+3,476
| +45% | +$143K | ﹤0.01% | 1131 |
|
|
2023
Q4 | $305K | Buy |
+7,690
| New | +$226K | ﹤0.01% | 1359 |
|
|
2023
Q3 | – | Sell |
-6,043
| Closed | -$205K | – | 1822 |
|
|
2023
Q2 | $205K | Buy |
+6,043
| New | +$204K | ﹤0.01% | 1525 |
|
|
2023
Q1 | – | Sell |
-5,896
| Closed | -$263K | – | 1813 |
|
|
2022
Q4 | $263K | Buy |
+5,896
| New | +$210K | ﹤0.01% | 1317 |
|
|
2022
Q2 | – | Sell |
-8,628
| Closed | -$293K | – | 1844 |
|
|
2022
Q1 | $293K | Sell |
8,628
-1,413
| -14% | -$45.2K | ﹤0.01% | 1643 |
|
|
2021
Q4 | $388K | Buy |
10,041
+4,146
| +70% | +$181K | ﹤0.01% | 1627 |
|
|
2021
Q3 | $318K | Sell |
5,895
-4,276
| -42% | -$201K | ﹤0.01% | 1504 |
|
|
2021
Q2 | $340K | Buy |
+10,171
| New | +$279K | ﹤0.01% | 1806 |
|
|
2018
Q4 | – | Sell |
-4,416
| Closed | -$30K | – | 1598 |
|
|
2018
Q3 | $30K | Buy |
4,416
+399
| +10% | +$2.79K | ﹤0.01% | 1745 |
|
|
2018
Q2 | $30K | Sell |
4,017
-1,296
| -24% | -$17.3K | ﹤0.01% | 1773 |
|
|
2018
Q1 | $186K | Sell |
5,313
-873
| -14% | -$33.8K | ﹤0.01% | 1565 |
|
|
2017
Q4 | $264K | Buy |
6,186
+812
| +15% | +$34.8K | ﹤0.01% | 1473 |
|
|
2017
Q3 | $231K | Buy |
5,374
+380
| +8% | +$14.2K | ﹤0.01% | 1238 |
|
|
2017
Q2 | $185K | Sell |
4,994
-90
| -2% | -$3.98K | ﹤0.01% | 1358 |
|
|
2017
Q1 | $275K | Sell |
5,084
-399
| -7% | -$20.8K | ﹤0.01% | 1279 |
|
|
2016
Q4 | $291K | Buy |
5,483
+632
| +13% | +$36K | ﹤0.01% | 1381 |
|
|
2016
Q3 | $294K | Sell |
4,851
-827
| -15% | -$51.5K | ﹤0.01% | 1157 |
|
|
2016
Q2 | $374K | Buy |
5,678
+4
| +0.1% | +$254 | ﹤0.01% | 1092 |
|
|
2016
Q1 | $322K | Sell |
5,674
-570
| -9% | -$64.1K | ﹤0.01% | 1180 |
|
|
2015
Q4 | $1.47M | Buy |
6,244
+604
| +11% | +$132K | 0.02% | 605 |
|
|
2015
Q3 | $892K | Sell |
5,640
-434
| -7% | -$123K | 0.01% | 709 |
|
|
2015
Q2 | $2.3M | Sell |
6,074
-279
| -4% | -$111K | 0.03% | 468 |
|
|
2015
Q1 | $2.66M | Buy |
6,353
+1,121
| +21% | +$401K | 0.03% | 481 |
|
|
2014
Q4 | $1.43M | Sell |
5,232
-203
| -4% | -$50.5K | 0.02% | 690 |
|
|
2014
Q3 | $1.06M | Sell |
5,435
-1,081
| -17% | -$236K | 0.01% | 1056 |
|
|
2014
Q2 | $1.59M | Sell |
6,516
-4,052
| -38% | -$915K | 0.02% | 918 |
|
|
2014
Q1 | $2.8M | Buy |
10,568
+7,751
| +275% | +$2.97M | 0.04% | 552 |
|
|
2013
Q4 | $1.02M | Sell |
2,817
-2,486
| -47% | -$958K | 0.02% | 974 |
|
|
2013
Q3 | $2.82M | Buy |
5,303
+778
| +17% | +$267K | 0.07% | 266 |
|
|
2013
Q2 | $1.06M | Buy |
+4,525
| New | +$891K | 0.02% | 811 |
|
Other funds holding CLDX
KCM
VCM
CC
EP